A Phase IV Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety of Immediate (Antepartum-Initiated) Versus Deferred (Postpartum-Initiated) Isoniazid Preventive Therapy Among HIV-Infected Women in High Tuberculosis (TB) Incidence Settings.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Isoniazid (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 20 Nov 2018 Biomarkers information updated
- 07 Jan 2014 Planned End Date changed from 1 Sep 2016 to 1 Feb 2017 as reported by ClinicalTrials.record.
- 29 May 2013 Planned end date changed from 1 Jan 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov.